Latest Releases

Following the shooting at a Texas elementary school yesterday, Northwestern Medicine psychologists discuss the traumatic impact on parents and children around the country and explain how to talk to children about the tragic event, sharing how he reassured his 11-year-old child.
* Media Advisory

Northwestern University engineers have developed the smallest-ever remote-controlled walking robot — and it comes in the form of a tiny, adorable peekytoe crab.

Findings from a new Northwestern Medicine study rebut the idea that Black individuals’ higher risk of cardiovascular disease is because of biological differences.

Northwestern University political science professor Alvin Tillery is available to comment on Georgia’s gubernatorial primary election and what it may signal for the GOP.
* Media Advisory

Pregnancy complications among individuals between the ages of 15 and 44 are increasing dramatically, a new Northwestern Medicine study has found. The rate of high blood pressure-related disorders among pregnant individuals more than doubled over a recent 12-year period.

In the new study, researchers used the tiny transparent roundworm C. elegans, a well-established model organism commonly used in biology research. Exposure of female roundworms to male pheromones slowed down the aging of the females’ egg cells, resulting in healthier offspring.

A national poll seeking to understand where parents get information about vaccinating their children against COVID-19 found parents of vaccinated children and parents of unvaccinated children divided over the best sources of information. The poll was conducted by the COVID States Project, a consortium of universities comprised of Northwestern, Harvard, Northeastern and Rutgers.

Dillo Day

When a non-metastatic brain tumor — a meningioma — recurs after surgery and radiation treatment, a patient is out of options. No drugs are approved for these aggressive tumors, which occur in up to 20% of cases and can lead to patient disability or even death.

New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease.